. 2011 Jun;6(6):1248–1257. doi: 10.2215/CJN.07180810

Table 4.

Incremental costs, incremental health-related quality of life (QALYs), and cost-effectiveness analysis

	Costs	QALYs	ICER
Cost-effectiveness results (disease-related costs)
intervention	$4631	1.502
control	$5741	1.456
incremental^a	−$1109	0.046	Dominant^b
Cost-effectiveness results (all costs)
intervention	$11,739	1.502
control	$14,180	1.456
incremental^a	−$2441	0.046	Dominant^b

Results in Table 4 include imputed data and differ from Table 3 because of imputation and discounting 2nd-year costs and QALYs by 5%.

Incremental, intervention − control.

Less costly, more QALYs.